Courtesy of Benzinga.
Analysts at Piper Jaffray initiated coverage on shares of Auspex Pharma (NASDAQ: ASPX) with a Overweight rating.
The target price for Auspex Pharma is set to $50.
Auspex Pharma shares surged 0.48% to close at $27.16 yesterday.
Latest Ratings for ASPX
Date | Firm | Action | From | To |
---|---|---|---|---|
Oct 2014 | Piper Jaffray | Initiates Coverage on | Overweight | |
Sep 2014 | Ladenburg Thalmann | Initiates Coverage on | Buy | |
Aug 2014 | Stifel Nicolaus | Maintains | Buy |
View More Analyst Ratings for ASPX
View the Latest Analyst Ratings
Posted-In: Piper JaffrayInitiation Analyst Ratings